EDN1 and pulmonary arterial hypertension: Among the best studied are the vasodilatory arachidonic acidmetabolite prostacyclin and free radical nitric oxide (NO), as well as thevasoconstrictive peptide hormone endothelin-1 (ET-1, also known as EDN1);manipulation of these vasoactive mediators forms the basis of currentpharmacotherapy in PAH [13].